Significance of hydrogen sulfide production in the pancreatic β-cell

Journal of Pharmacological Sciences

Volumn 116, Issue 1, 2011, Pages 1-5

  Taniguchi, Shigeki ^a   Niki, Ichiro ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Cytoprotection; Diabetes mellitus; Gasotransmitter; Hydrogen sulfide; Pancreatic cell

Indexed keywords

CARBON MONOXIDE; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; CYSTEINE; GLUCOSE; GLUTATHIONE; HYDROGEN SULFIDE; INSULIN; NITRIC OXIDE;

BIOSYNTHESIS; CELL DEATH; CELL PROTECTION; CELL STIMULATION; CELL SURVIVAL; CELL VOLUME; DIABETES MELLITUS; DISEASE COURSE; HUMAN; INSULIN RELEASE; LONG TERM EXPOSURE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PATHOGENESIS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE;

EID: 79956187764     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.11R01CP     Document Type: Review

References (34)

1. Warenycia MW, Reiffenstein RJ, Goodwin LR, Dieken FP. Brain sulfide levels in anaesthesia: a comparison with hydrogen sulfide intoxication. Toxicol Lett. 1989;47:221-224. (Pubitemid 19149127)
2. Goodwin LR, Francom D, Dieken FP, Taylor JD, Warenycia MW, Reiffenstein RJ, et al. Determination of sulfide in brain tissue by gas dialysis/ion chromatography: postmortem studies and two case reports. J Anal Toxicol. 1989;13:105-109. (Pubitemid 19084165)
3. Maclean KN, Kraus JP. Hydrogen sulfide production and metabolism in mammalian tissues. In: Wang R editor. In signal transduction and the gasotransmitters. New Jersey: Humana Press; 2004. p. 275-292.
4. 2S) - the third gas of interest for pharmacologists. Pharmacol Rep. 2007;59:4-24.
5. Li L, Moore PK. Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air? Trends Pharmacol Sci. 2008;29:84-90.
6. Kimura H. Hydrogen sulfide: its production, release and functions. Amino Acids. 2010; DOI 10.1007/s00726-010-0510-x.
7. Shibuya N, Tanaka M, Yoshida M, Ogasawara Y, Togawa T, Ishii K, et al. 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid Redox Signal. 2009;11:703-714.
8. Nagahara N, Ito T, Kitamura H, Nishino T. Tissue and subcellular distribution of mercaptopyruvate sulfurtransferase in the rat: confocal laser fluorescence and immunoelectron microscopic studies combined with biochemical analysis. Histochem Cell Biol. 1998;110:243-250. (Pubitemid 28401732)
9. 2S). Cell Biochem Funct. 2010;28:95-106.
10. Abe K, Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci. 1996;16:1066-1071. (Pubitemid 26140863)
11. Hosoki R, Matsuki N, Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun. 1997;237:527-531. (Pubitemid 27434718)
12. Dello Russo C, Tringali G, Ragazzoni E, Maggiano N, Menini E, Vairano M, et al. Evidence that hydrogen sulphide can modulate hypothalamo-pituitary- adrenal axis function: In vitro and in vivo studies in the rat. J Neuroendocrinol. 2000;12:225-233. (Pubitemid 30156514)
13. 2S and cellular proliferation and apoptosis. Acta Physiologica Sinica. 2007;59:133-140.
14. Mancardi D, Penna C, Merlino A, Del Soldato P, Wink DA, Pagliaro P. Physiological and pharmacological features of the novel gasotransmitter: Hydrogen sulfide. Biochim Biophys Acta. 2009;1787:864-872.
15. 2S signals through protein S-sulfhydration. Sci Signal. 2009;2:ra72.
16. 2S in rat insulin-secreting cells and the underlying mechanisms. J Physiol. 2005;569:519-531.
17. ATP channel-dependent pathway. J Endocrinol. 2007;195:105-112.
18. Kaneko Y, Kimura Y, Kimura H, Niki I. L-cysteine inhibits insulin release from the pancreatic β-cell: possible involvement of metabolic production of hydrogen sulfide, a novel gasotransmit ter. Diabetes. 2006;55:1391-1397. (Pubitemid 44195378)
19. Kaneko Y, Kimura T, Taniguchi S, Souma M, Kojima Y, Kimura Y, et al. Glucose-induced production of hydrogen sulfide may protect the pancreatic beta-cells from apoptotic cell death by high glucose. FEBS Lett. 2009;583:377-382.
20. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
21. Wu L, Wang R. Carbon monoxide: Endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev. 2005;57:585-630. (Pubitemid 43036442)
22. 2S and suppressed insulin release in Zucker diabetic rats. Lab Invest. 2009;89:59-67.
23. Yang G, Yang W, Wu L, Wang R. H2S, endoplasmic reticulum stress, and apoptosis of insulin-secreting beta cells. J Biol Chem. 2007;282:16567-16576. (Pubitemid 47100397)
24. Taniguchi S, Kang L, Kimura T, Niki I. Hydrogen sulphide protects mouse pancreatic β-cells from cell death induced by oxidative stress, but not by endoplasmic reticulum stress. Br J Pharmacol. 2011;162:1171-1178.
25. 2+ concentration. J Biol Chem. 1998;273:33501-33507.
26. Nieman KM, Rowling MJ, Garrow TA, Schalinske KL. Modulation of methyl group metabolism by streptozotocin-induced diabetes and all-trans-retinoic acid. J Biol Chem. 2004;279:45708-45712. (Pubitemid 39491560)
27. Yusuf M, Kwong Huat BT, Hsu A, Whiteman M, Bhatia M, Moore PK. Streptozotocin-induced diabetes in the rat is associated with enhanced tissue hydrogen sulfide biosynthesis. Biochem Biophys Res Commun. 2005;333:1146-1152. (Pubitemid 40910123)
28. Jacobs RL, House JD, Brosnan ME, Brosnan JT. Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat. Diabetes. 1998;47:1967-1970. (Pubitemid 28549207)
29. 2S is impaired in non-obese diabetic (NOD) mice. Br J Pharmacol. 2008;155:673-680.
30. Whiteman M, Gooding KM, Whatmore JL, Ball CI, Mawson D, Skinner K, et al. Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulphide. Diabetologia. 2010;53:1722-1726.
31. Jain SK, Bull R, Rains JL, Bass PF, Levine SN, Reddy S, et al. Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin- treated rats causes vascular inflammation? Antioxid Redox Signal. 2010;12:1333-1338.
32. Predmore BL, Lefer DJ. Development of dydrogen sulfide-based therapeutics for cardiovascular disease. J Cardiovasc Transl Res. 2010;3:487-498.
33. Szabó C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov. 2007;6:917-935. (Pubitemid 350042399)
34. Wajchenberg BL. β-cell failure in diabetes and preservation by clinical treatment. Endocr Rev. 2007;28:187-218. (Pubitemid 46984834)